Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Abbott 48999
2. Abbott-48999
3. Abbott48999
4. Cefotiam
5. Cefotiam Hydrochloride
6. Ceradolan
7. Cgp 14221 E
8. Cgp-14221-e
9. Cgp14221e
10. Haloapor
11. Halospor
12. Hydrochloride, Cefotiam
13. Sce 963
14. Sce-963
15. Sce963
1. Cefotiam Hydrochloride
2. 66309-69-1
3. Dsstox_cid_25538
4. Dsstox_rid_80940
5. Dsstox_gsid_45538
6. (6r,7r)-7-[[2-(2-amino-1,3-thiazol-4-yl)acetyl]amino]-3-[[1-[2-(dimethylamino)ethyl]tetrazol-5-yl]sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrochloride
7. Cas-66309-69-1
8. Nsc-758164
9. Sr-01000841230
10. Cefotiam Monohydrochloride
11. Ncgc00016998-01
12. Schembl65480
13. Mls002153835
14. Chembl1200589
15. Dtxsid40860766
16. Hms1569b05
17. Tox21_110730
18. Akos032960346
19. Tox21_110730_1
20. Ccg-220482
21. Ncgc00179594-03
22. (6r-trans)-7-[2-(2-aminothiazol-4-yl)acetamido]-3-[[[1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl]thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Hydrochloride
23. Smr001233198
24. Sr-01000841230-3
25. W-104762
26. Cefotiam Hydrochloride, Antibiotic For Culture Media Use Only
27. 1428118-46-0
28. 5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid,7-[[(2-amino-4-thiazolyl)acetyl]amino]-3-[[[1-[2-(dimethylamino)ethyl]-1h-tetrazol-5-yl]thio]methyl]-8-oxo-, Dihydrochloride, (6r,7r)-
| Molecular Weight | 562.1 g/mol |
|---|---|
| Molecular Formula | C18H24ClN9O4S3 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 13 |
| Rotatable Bond Count | 10 |
| Exact Mass | 561.0801915 g/mol |
| Monoisotopic Mass | 561.0801915 g/mol |
| Topological Polar Surface Area | 251 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 848 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
72
PharmaCompass offers a list of Cefotiam Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefotiam Hydrochloride manufacturer or Cefotiam Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cefotiam Hydrochloride manufacturer or Cefotiam Hydrochloride supplier.
A Cefotiam hcl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefotiam hcl, including repackagers and relabelers. The FDA regulates Cefotiam hcl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefotiam hcl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cefotiam hcl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cefotiam hcl supplier is an individual or a company that provides Cefotiam hcl active pharmaceutical ingredient (API) or Cefotiam hcl finished formulations upon request. The Cefotiam hcl suppliers may include Cefotiam hcl API manufacturers, exporters, distributors and traders.
click here to find a list of Cefotiam hcl suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cefotiam hcl Drug Master File in Japan (Cefotiam hcl JDMF) empowers Cefotiam hcl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cefotiam hcl JDMF during the approval evaluation for pharmaceutical products. At the time of Cefotiam hcl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cefotiam hcl suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefotiam hcl Drug Master File in Korea (Cefotiam hcl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefotiam hcl. The MFDS reviews the Cefotiam hcl KDMF as part of the drug registration process and uses the information provided in the Cefotiam hcl KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefotiam hcl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefotiam hcl API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefotiam hcl suppliers with KDMF on PharmaCompass.
Cefotiam hcl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefotiam hcl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cefotiam hcl GMP manufacturer or Cefotiam hcl GMP API supplier for your needs.
A Cefotiam hcl CoA (Certificate of Analysis) is a formal document that attests to Cefotiam hcl's compliance with Cefotiam hcl specifications and serves as a tool for batch-level quality control.
Cefotiam hcl CoA mostly includes findings from lab analyses of a specific batch. For each Cefotiam hcl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefotiam hcl may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefotiam hcl EP), Cefotiam hcl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefotiam hcl USP).